Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics

Respiratory Medicine

Volumn 100, Issue 12, 2006, Pages 2144-2150

  Micheletto, Claudio ^a   Tognella, Silvia ^a   Visconti, Marilia ^a   Trevisan, Fiorenza ^a   Dal Negro, Roberto W ^a  

^a Ospedale   (Italy)

Author keywords

Aspirin induced asthma; LTE4 excretion; Nasal provocation test with L ASA

Indexed keywords

ARACHIDONIC ACID; CREATININE; LEUKOTRIENE E4; LIPOXYGENASE; LYSINE ACETYLSALICYLATE; PEPTIDOLEUKOTRIENE; ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS OBSTRUCTION; CONTROLLED STUDY; CREATININE URINE LEVEL; DIAGNOSTIC VALUE; DISCRIMINANT ANALYSIS; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; ENZYME IMMUNOASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFORMED CONSENT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOSE OBSTRUCTION; NOSE POLYP; NOSE PROVOCATION TEST; PATHOGENESIS; PATIENT SAFETY; PRIORITY JOURNAL; PROSTAGLANDIN URINE LEVEL; RHINOMANOMETRY; SENSITIVITY ANALYSIS; SPIROMETRY; STUDENT T TEST; URINARY EXCRETION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; NOSE; NOSE CAVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RHINOMETRY; URINE;

ADMINISTRATION, INTRANASAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOTRIENE E4; MALE; MIDDLE AGED; NASAL CAVITY; NASAL PROVOCATION TESTS; NOSE; RHINOMETRY, ACOUSTIC;

EID: 33749462716     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.03.017     Document Type: Article

References (29)

1. Samter M., and Beers R.F. Intolerance to ASA. Clinical studies and consideration of its pathogenesis. Ann Intern Med 68 (1968) 975-983
2. Szczeklik A., Nizankowska E., Duplaga M., and On behalf of the AIANE investigators. Natural history of aspirin-induced asthma. Eur Respir J 16 (2000) 432-436
3. Szczeklik A., and Stevenson D.D. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111 (2003) 913-921
4. Szczeklik A., Gryglewski R.J., and Czerniawska-Mysik G. Relatioship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1 (1975) 67-69
5. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 3 (1990) 588-593
6. Lee T.H. Mechanisms of aspirin sensitivity. Am Rev Respir Dis 145 (1992) S34-S36
7. 4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 23 (2000) 290-296
8. Kowalski M.L., Pawliczak R., Wozniak J., Siuda K., Ponitowaska M., Jwaszkiewicz L., et al. Different metabolism of arachinodic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 161 (2000) 391-398
9. Pérez-Novo C.A., Watelet J.B., Claeys C., Van Cauwenberge P., and Bachert C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 115 (2005) 1189-1196
10. Picado C., Fernandez-Morata J.C., Juan M., Roca-Ferrer J., Fuentes M., Xaubet A., et al. Cycloxygenase-2 mRNA is downexressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 160 (1999) 291-296
11. Smith C.M., Hawksworth R.J., Thien F.C.K., Christie P.E., and Lee T.H. Urinary leukotriene E4 in bronchial asthma. Eur Respir J 5 (1992) 693-699
12. Israel E., Fischer A.R., Rosenberg M.A., et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 148 (1993) 1447-1451
13. Oosaki R., Mizushima Y., Mita H., Shida T., Akiyama K., and Kobayashi M. Urinay leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. Allergy 52 (1997) 470-473
14. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 143 (1991) 1025-1029
15. 4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 104 (1999) 559-564
16. Nizankoswska E., Bestynska-Krypel A., Cmiel A., and Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis os aspirin-induced asthma. Eur Respir J 15 (2000) 863-869
17. 4 and histamine in asthmatics. Am Rev Respir Dis 146 (1992) 96-103
18. Mita H., Higashi N., Taniguchi M., Higashi A., and Akiyama K. Increase in urinary leuKotriene B4 glucoronide concentration in patients with aspirin intolerant asthma after intravenous aspirin challenge. Clin Exp Allergy 34 (2004) 1262-1269
19. Milewski M., Mastalerz L., Nizankowska E., and Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 101 (1998) 581-586
20. Casadevall J., Ventura P.-J., Mullol J., and Picado C. Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry. Thorax 55 (2000) 921-924
21. Micheletto C., Tognella S., Visconti M., Pomari C., Trevisan F., and Dal Negro R.W. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo. Allergy 59 (2004) 289-294
22. Lai V., and Corey J. The use of acoustic rhinometry to quantitatively assess changes after intranasal allergen challenge. Am J Rhinol 8 (1994) 171-173
23. Pradelles P., Grassi J., and Maclouf J.A. Enzyme immunoassays of ecosanoids using acetylcholinesterase as label: an alternative to radioimmunoassay. Anal Chem 57 (1985) 1170-1173
24. Szczeklik A., and Nizankowska E. Pharmacological agents in bronchial provocation test. In: Allegra L., Braga P.C., and Dal Negro R. (Eds). Methods in asthmology (1993), Springer, Berlin, Germany 253-264
25. Bianco S., Robuschi M., and Petrigni G. Aspirin-induced tolerance in aspirin-induced asthma detected by a new challenge technique. IRCS J Med 5 (1977) 129-130
26. Dahlen B., and Zetterstroem O. Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J 3 (1990) 527-534
27. Lee D.K., Haggart K., and Lipworth B.J. Reproducibility of response to nasal lysine-aspirin challenge in patients with aspirin induced asthma. Ann Allergy Asthma Immunol 93 (2004) 185-188
28. Dahlén S.E., Malstrom K., Nizankowska E., et al. Improvement of aspirin-intolerant asthma by Montelukast, a leukotriene antagonist. Am J Respir Crit Care Med 165 (2002) 9-14
29. Lee D.K., Haggart K., Robb F.M., and Lipworth B.J. Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin induced asthma. Eur Respir J 24 (2004) 226-230